MATTHEW WAYT: Open Payments
NPI 1427085844 · ORRVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 39 payments from 15 companies in 2025. Trend: 2023 $155 · 2024 $672 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $260 |
| Otsuka America Pharmaceutical, Inc. | 5 | $90 |
| Astellas Pharma US Inc | 4 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Amgen Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
Products named: VRAYLAR, REXULTI, UBRELVY, Veozah, CAPLYTA, EVENITY, MOUNJARO, GEMTESA.
Industry payments across OH — which companies pay providers there.
